| 基于全局主成分和聚类分析法的中药上市企业竞争力动态研究 |
| |
| 引用本文： | 金金,吴亚坤,罗素平,袁红梅.基于全局主成分和聚类分析法的中药上市企业竞争力动态研究[J].中草药,2019,50(11):2750-2756. |
| |
| 作者姓名： | 金金 吴亚坤 罗素平 袁红梅 |
| |
| 作者单位： | 沈阳药科大学工商管理学院, 辽宁沈阳 110016,沈阳药科大学工商管理学院, 辽宁沈阳 110016,沈阳药科大学工商管理学院, 辽宁沈阳 110016,沈阳药科大学工商管理学院, 辽宁沈阳 110016 |
| |
| 基金项目： | 辽宁省教育厅高校基本科研项目资助：基于技术创新的中药企业国际竞争力提升路径研究（2017WZD04） |
| |
| 摘 要： | 选取2013-2017年47家中药上市企业的12项指标，构建企业竞争力评价体系。首先采用全局主成分分析法将12项指标聚成4个主成分，并分别命名为规模能力、盈利能力、成长能力和技术创新能力，并计算企业竞争力得分；其次在企业竞争力得分基础上，运用Q型聚类分析法将企业分成4个类型，然后运用动静结合的方式，从静态、动态角度分别分析4类企业的发展状态；最后得出相关结论和建议，让企业有的放矢地制定发展战略。
|
| 关 键 词： | 中药上市企业 企业竞争力 指标体系 全局主成分分析 聚类分析 |
| 收稿时间： | 2019/1/5 0:00:00 |
Dynamic research on competitiveness of Chinese materia medica listed enterprises based on global principal component and cluster analysis method |
| |
| JIN Jin,WU Ya-kun,LUO Su-ping and YUAN Hong-mei.Dynamic research on competitiveness of Chinese materia medica listed enterprises based on global principal component and cluster analysis method[J].Chinese Traditional and Herbal Drugs,2019,50(11):2750-2756. |
| |
| Authors: | JIN Jin WU Ya-kun LUO Su-ping and YUAN Hong-mei |
| |
| Institution: | College of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China,College of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China,College of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China and College of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China |
| |
| Abstract: | This paper selects 12 indicators of 47 Chinese materia medica (CMM) listed companies from 2013 to 2017, and builds an enterprise competitiveness evaluation system. Firstly, the global principal component analysis (GPCA) method is used to aggregate 12 indicators into four principal components, which named as scale capability, profitability, growth ability and technological innovation ability, and calculate the competitiveness score of the enterprise. Secondly, the Q-type cluster analysis method is used to divide the enterprise into four echelons based on the competitiveness score of the enterprise, and then use the combination of dynamic and static to analyze the development status of the four types of enterprises from static and dynamic perspectives. This study finally drew relevant conclusion and suggestions, providing reference for the companies making a targeted development strategy. |
| |
| Keywords: | Chinese materia medica listed companies enterprise competitiveness indicator system global principal component analysis cluster analysis |
|
| 点击此处可从《中草药》浏览原始摘要信息 |
| 点击此处可从《中草药》下载免费的PDF全文 |
|
